ARCT - Arcturus Therapeutics Holdings - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ARCT is currently covered by 11 analysts with an average price target of $24.32. This is a potential upside of $10.63 (77.65%) from yesterday's end of day stock price of $13.69.

Arcturus Therapeutics Holdings's activity chart (see below) currently has 192 price targets and 192 ratings on display. The stock rating distribution of ARCT is 63.16% BUY and 36.84% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 45.01% with an average time for these price targets to be met of 218.3 days.

Highest price target for ARCT is $68, Lowest price target is $8, average price target is $24.32.

Most recent stock forecast was given by THOMAS SHRADER from BTIG on 24-Sep-2026. First documented stock forecast 04-Feb-2016.

Currently out of the existing stock ratings of ARCT, 12 are a BUY (63.16%), 7 are a HOLD (36.84%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 28-Jan-2025

$20

$6.15 (44.40%)

$23

7 days ago
(24-Sep-2026)

0/5 (0%)

$5.88 (41.64%)

Hold Since 13-Nov-2025

$20

$6.15 (44.40%)

$8

7 days ago
(24-Sep-2026)

7/14 (50%)

$5.88 (41.64%)

142

Buy Since 02-Jul-2026

$27

$13.15 (94.95%)

2 months 29 days ago
(02-Jul-2026)

0/1 (0%)

$19.72 (270.88%)

Hold Since 18-Mar-2026

$22

$8.15 (58.84%)

$23

6 months 13 days ago
(18-Mar-2026)

6/9 (66.67%)

$15.45 (235.88%)

99

Buy Since 07-Feb-2020

$21

$7.15 (51.62%)

6 months 26 days ago
(05-Mar-2026)

1/9 (11.11%)

$13.75 (189.66%)

75

Show more analysts

Please expand the browser size to see the chart

What is ARCT (Arcturus Therapeutics Holdings) average time for price targets to be met?

On average it took 218 days for the stock forecasts to be reached, with an average price target met ratio of 45.01%.

Which analyst most recently updated their price target on ARCT (Arcturus Therapeutics Holdings)?

Thomas Shrader

Which analyst has the most public recommendations on ARCT (Arcturus Therapeutics Holdings)?

Thomas Shrader works at BTIG and has 9 price targets and 8 ratings on ARCT

Which analyst is the currently most bullish on ARCT (Arcturus Therapeutics Holdings)?

Kumaraguru Raja with the highest potential upside of $79.15

Which analyst is the currently most reserved on ARCT (Arcturus Therapeutics Holdings)?

Michael Higgins with the lowest potential downside of -$6.85
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?